case_images: PMC10839542_01
case_images: Chest high-resolution computed tomography at the patient's first visit (A) and 13 days after treatment initiation with trimethoprim-sulfamethoxazole, prednisolone, and ganciclovir (B).
case_images: cureus-0016-00000051724-i01.jpg
case_images: PMC10839542_02_cureus-0016-00000051724-i01.jpg
case_images: FIG1
case_images: Follow-up HRCT 13 days after treatment initiation (day 13) revealed that the GGOs in both lungs diminished (Figure 1B).
case_images: Grocott staining reveals capsular dots in the bronchoalveolar lavage fluid, consistent with Pneumocystis jirovecii infection.
case_images: cureus-0016-00000051724-i02.jpg
case_images: PMC10839542_01_cureus-0016-00000051724-i02.jpg
case_images: FIG2
case_images: Bronchoalveolar lavage fluid (BALF) analysis showed lymphocyte predominance (28.3%), and Grocott's stain of BALF revealed the presence of P. jirovecii (Figure 2), and PCR for P. jirovecii using BALF was positive.
case_images: PMC10839542_02
case_images: Chest high-resolution computed tomography at the patient's first visit (A) and 13 days after treatment initiation with trimethoprim-sulfamethoxazole, prednisolone, and ganciclovir (B).
case_images: cureus-0016-00000051724-i01.jpg
case_images: PMC10839542_02_cureus-0016-00000051724-i01.jpg
case_images: FIG1
case_images: Follow-up HRCT 13 days after treatment initiation (day 13) revealed that the GGOs in both lungs diminished (Figure 1B).